Improving Diagnosis and Treatment of Atopic Dermatitis through Collaborative Primary & Specialist Care Evaluation (ID: i722a) Survey

Question Title

* 1. Following participation in this activity, how confident are you in the management of patients with AD in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 2. How many patients with AD do you manage in your practice?

Question Title

* 3. Following participation in this activity, please select which of the following items you will include in patient education plans in your current practice. (Select all that apply)

Written treatment plans

Recommendation to moisturize frequently

Information that topical medications do not take the place of moisturizers

Importance of adherence

Recommendation to continue maintenance treatments even when skin appears healthy

Question Title

* 4. After participating in today’s activity, I have improved knowledge of clinical data supporting use of new and emerging therapies for AD.

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

Question Title

* 5. As a result of participating in this activity, will you change components of your communication with patients with AD? If so, please describe changes.

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

I will implement the information in my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 7. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

Question Title

* 8. After participating in this activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients Strongly agree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients Agree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients Neutral	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients Disagree	Utilize updated criteria and guidelines to accurately diagnose AD and assess severity in individual patients Strongly disagree
Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD	Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD Strongly agree	Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD Agree	Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD Neutral	Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD Disagree	Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD Strongly disagree
Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians	Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians Strongly agree	Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians Agree	Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians Neutral	Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians Disagree	Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate-to-severe disease with specialist physicians Strongly disagree
List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD	List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD Strongly agree	List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD Agree	List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD Neutral	List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD Disagree	List documentation and prior authorization requirements to ensure access to prescribed medications for patients with AD Strongly disagree

Question Title

* 9. Jonathan I. Silverberg, MD, PhD, MPH, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 10. Stephen Brunton, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 11. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 12. What barriers do you see to making changes in your practice?

Question Title

* 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. How would you rate the format of this activity?

Excellent

Average

Below average

Poor